Hemostatic antibacterial injectable microsphere for submucosal dissection and preparation method thereof

By developing hemostatic antibacterial microspheres based on cysteine ​​and serum amine graft modification of oxidized sodium alginate and trivalent iron ions, the problems of hemostatic and infection during endoscopic submucosal dissection were solved, and rapid hemostatic stasis was achieved , effectively antibacterial and promote healing, reducing the risk and time of surgery.

CN119015514APending Publication Date: 2024-11-26ZHENGZHOU UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411151603.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-21
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

There is difficulty in stopping hemostatic and infection risk during endoscopic submucosal dissection. The strong permeability of existing normal saline injections leads to a short lifting time, requiring multiple injections, increasing the operation time and risk, and not effectively preventing wound bleeding and infection.

Method used

Develop a hemostatic antibacterial injectable microsphere based on cysteine ​​and serum amine graft modification of oxidized sodium alginate and trivalent iron ions. It achieves photothermal response and antibacterial effect through near-infrared light irradiation, with good Tissue adhesion and antioxidant properties.

Benefits of technology

It achieves rapid hemostasis, effective antibacterial, promotes healing, reduces surgical time and perforation risks, provides a stable surgical field of view and a safe wound environment, significantly improves the height and time of mucosal bulge, and ensures smooth operation.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005003810040000061
    Figure BDA0005003810040000061
  • Figure BDA0005003810040000071
    Figure BDA0005003810040000071
  • Figure BDA0005003810040000072
    Figure BDA0005003810040000072
Patent Text Reader

Abstract

The invention belongs to the field of biological material technology and medical products, and particularly relates to a hemostatic antibacterial injectable microsphere for submucosal dissection and a preparation method of the hemostatic antibacterial injectable microsphere. The invention provides a hemostatic antibacterial injectable microsphere for submucosal dissection and a preparation method of the hemostatic antibacterial injectable microsphere for the submucosal dissection, wherein the hemostatic antibacterial injectable microsphere is formed by compounding oxidized sodium alginate modified based on cysteine and seroamine and ferric ions, and the hemostatic antibacterial injectable microsphere is formed by compounding sodium alginate and ferric ions. The mucous membrane lifting height and stabilizing time in the operation can be effectively increased, the operation time is shortened, and the perforation risk is reduced; besides, effective and rapid hemostasis is completed on the mucous membrane dissection part through the physical and physiological synergistic effect, and meanwhile, continuous and excellent photo-thermal antibacterial and oxygen free radical scavenging performance is achieved, so that bacterium breeding of the submucous membrane dissection part is inhibited, and an effective guarantee is provided for rapid repair of a wound.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of biomaterial technology and medical products, and specifically relates to a hemostatic and antibacterial injectable microsphere for submucosal dissection and a preparation method thereof. Background Art

[0002] Endoscopic submucosal dissection (ESD) is a minimally invasive surgical method, which is improved from endoscopic submucosal resection (EMR). It mainly uses endoscopic technology and cutting tools to accurately remove the lesion tissue in the submucosal layer, and is used to intervene in early digestive tract cancer. The operation includes preoperative marking, injection of raised peeling layer, precise cutting of lesions and real-time hemostasis, and finally complete removal of lesion tissue.

[0003] Endoscopic submucosal injection is one of the key materials in endoscopic surgery and is often used in the process of treating early gastrointestinal cancer such as endoscopic submucosal dissection. Normal saline is usually selected, and its main purpose is to fully raise the mucosal layer before surgery so that doctors can more easily cut and dissect the submucosal layer. Normal saline has the advantages of low price, easy operation and acquisition, and has shown good clinical effects in this operation without toxicity or harmful effects on tissues. However, due to its strong permeability and easy absorption by the submucosal tissue, the maintenance time of the raised mucosal layer is short and the height is low. Multiple injections are required during the operation to maintain the lifting of the mucosa. This may cause problems such as increased operation time and increased difficulty in operation, and increase the risk of perforation, which may lead to a decrease in the success rate of the operation. In addition, bleeding and infection during endoscopic submucosal dissection are also common complications. Wound bleeding will affect the operating field of the operation, and wound infection may cause serious damage to the human body, which is an important challenge faced by doctors during surgery. Therefore, there is an urgent need to invent a new type of injectable material for submucosal dissection that can stop bleeding and sterilize the dissected wound.

[0004] Micron-sized microspheres (particle size between 1 and 100 μm) have played an important role in biomedical engineering, drug delivery and clinical medicine in recent years. Special injections rich in microspheres can not only fully bulge the mucosal layer, providing doctors with a clear and relatively stable surgical field of view, which is conducive to the precise operation; in addition, the unique porous structure and large specific surface area of ​​microspheres facilitate surface modification through physical, biological and chemical effects, promote the efficient adsorption of plasma proteins, fibrinogen and blood cells in the blood, accelerate the formation of thrombus in the injured area, and are suitable for hemostasis processes in more complex lesions or in special locations.

[0005] The present application found that wound dressings modified by serotonin grafting can significantly improve the hemostatic properties of the material, while giving the material excellent tissue adhesion and antioxidant properties. In addition, the present application introduced trivalent iron ions with photothermal effect into the gel matrix, so that the composite gel produces a heating effect and sterilization effect on bacteria after near-infrared light irradiation, while retaining good compatibility with human cells. The above comprehensive performance shows that this type of material has great application potential in the process of wound hemostasis, repair and healing. Summary of the invention

[0006] In view of the problems and shortcomings in the prior art, the object of the present invention is to provide a hemostatic and antibacterial injectable microsphere for submucosal dissection and a preparation method thereof.

[0007] To achieve the purpose of the invention, the technical solution adopted by the present invention is as follows:

[0008] The first aspect of the present invention provides a hemostatic antibacterial injectable microsphere for submucosal dissection, wherein the hemostatic antibacterial injectable microsphere is based on cysteine ​​and serotonin graft-modified oxidized sodium alginate, sodium alginate and trivalent iron ions, and has an average particle size of 0.1 to 0.5 μm.

[0009] The second aspect of the present invention provides a method for preparing the above-mentioned hemostatic and antibacterial injectable microspheres, comprising the following steps:

[0010] (1) dissolving sodium periodate in a sodium alginate solution, stirring and mixing, and reacting in the dark for 8 hours, then adding ethylene glycol and continuing stirring for 1 hour to terminate the oxidation reaction to obtain a reaction solution, dialyzing the reaction solution, and freeze-drying to obtain oxidized sodium alginate;

[0011] (2) first adding 1-ethyl-(3-dimethylaminopropyl) carbodiimide hydrochloride to the oxidized sodium alginate solution, stirring for reaction, then adding L-cysteine ​​hydrochloride monohydrate, adjusting the pH of the solution to about 5 with a sodium hydroxide solution, and then reacting in the dark to obtain a reaction solution, dialyzing the reaction solution, and freeze-drying it to obtain cysteine-grafted oxidized sodium alginate;

[0012] (3) adding serotonin hydrochloride to the oxidized sodium alginate solution and stirring evenly, then adding 1-ethyl-(3-dimethylaminopropyl) carbodiimide hydrochloride and N-hydroxysuccinimide, adjusting the pH of the solution to 5.5 with a sodium hydroxide solution, and then reacting in the dark to obtain a reaction solution, dialyzing the reaction solution, and freeze-drying it to obtain serotonin grafted oxidized sodium alginate;

[0013] (4) The cysteine-grafted oxidized sodium alginate, serotonin-grafted oxidized sodium alginate and sodium alginate obtained above are mixed and dissolved in deionized water to prepare a uniform solution, which is then dripped into the oil phase and stirred to obtain an oil-in-water system; then the FeCl3 solution is dripped into the oil-in-water system, stirred for reaction, and a reaction emulsion is obtained; the reaction emulsion is centrifuged, the product is collected and washed, filtered, and freeze-dried to obtain the hemostatic and antibacterial injectable microspheres.

[0014] Preferably, in step (1), the molar ratio of sodium periodate to sodium alginate is (1-3):1.

[0015] Preferably, in step (2), the molar ratio of L-cysteine ​​hydrochloride monohydrate to oxidized sodium alginate is (1-2):1; the molar ratio of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride to oxidized sodium alginate is 1:1.

[0016] Preferably, in step (3), the molar ratio of serotonin hydrochloride to sodium alginate oxide is (1-2):1; the molar ratio of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride to N-hydroxysuccinimide is 2:1.

[0017] Preferably, in step (4), the mass ratio of cysteine-grafted oxidized sodium alginate, serotonin-grafted oxidized sodium alginate and sodium alginate is (1-3):(1-3):1.

[0018] Preferably, the concentration of the sodium hydroxide solution is 0.1 mol / L.

[0019] Preferably, the mass concentration of the uniform solution in step (4) is 2 g / L, the oil phase is liquid paraffin containing Span-80 and Tween-80, and the concentration of the FeCl3 solution is 2 mol / L.

[0020] The third aspect of the present invention provides a hemostatic and antibacterial injectable microsphere for submucosal dissection prepared by the preparation method described in the second aspect.

[0021] Compared with the prior art, the present invention has the following beneficial effects:

[0022] 1. Based on the components of the extracellular matrix and good biocompatible materials, an injectable microsphere with photothermal antibacterial response characteristics was invented. Specifically, after being irradiated with near-infrared light (wavelength 808nm), the temperature can be quickly raised to 55°C in a short time (about 3 minutes), and it can quickly return to room temperature (about 30 seconds) after the light source is removed. The microsphere has a good photothermal response and recovery effect, which lays the foundation for the realization of photothermal antibacterial function.

[0023] 2. The photothermal responsive injectable microspheres provided by the present invention can kill Escherichia coli and Staphylococcus aureus, with a sterilization rate close to 100%, providing a good sterile healing environment for the wound surface and promoting local tissue regeneration and wound healing.

[0024] 3. A large amount of oxygen free radicals are usually produced locally in the wound, which is likely to cause secondary damage to the wound and adjacent tissues. The injectable microspheres proposed in the present invention have excellent antioxidant properties, can effectively eliminate oxygen free radicals, and provide a suitable environment for normal wound healing.

[0025] 4. The injectable microspheres provided by the present invention have good tissue adhesion and can quickly adsorb blood cells in the lesion area after mucosal stripping is completed; in addition, the hemostasis process is completed based on the synergistic effect of serotonin and iron ions in the microspheres. The response mechanism includes serotonin activating the human hemostasis signaling pathway and the rapid and effective adsorption of iron ions on blood cells, which provides an effective guarantee for rapid hemostasis and later healing of wounds.

[0026] 5. The injectable microspheres provided by the present invention can reach the lesion with a relatively small injection pressure (<1.5N), and at the same time comprehensively improve the lifting height (about 8mm) and stabilization time (about 5min) of the mucosa during surgery, provide a safe operating height for mucosal peeling, reduce the operation time and perforation risk, and provide an effective guarantee for the smooth progress of the operation. BRIEF DESCRIPTION OF THE DRAWINGS

[0027] Figure 1 for (a)SA / cOSA Fe (b) SA / OSAS Fe 、(c)SA / cOSAS Fe (A) SEM image, (B) particle size distribution image and (C) average particle size image;

[0028] Figure 2 for (A)SA / cOSA Fe 、SA / OSAS Fe 、SA / cOSAS Fe Temperature change images of microspheres under 808nm near-infrared light irradiation, (B) heating curve of microspheres under near-infrared light irradiation and (C) cooling curve of microspheres after turning off near-infrared light;

[0029] Figure 3 SA / cOSA before and after 808nm near-infrared light irradiation for 10 minutes Fe 、SA / OSAS Fe 、SA / cOSAS Fe Inhibition images and inhibition rate statistics of microspheres on (A) S. aureus and (B) E. coli colonies;

[0030] Figure 4 For (I)PBS, (II)SA / cOSA Fe (III) SA / OSAS Fe and (IV) SA / cOSAS Fe Comparison of scavenging rates of (A) DPPH and (B) ABTS free radicals;

[0031] Figure 5 For SA / cOSA Fe 、SA / OSAS Fe 、SA / cOSAS Fe Microspheres' (A) coagulation reaction process, (B) coagulation index statistics, (C) red blood cell rupture images, and (D) hemolysis rate statistics;

[0032] Figure 6 . For normal saline, SA / cOSA Fe 、SA / OSAS Fe 、SA / cOSAS Fe (A) Submucosal injection experimental image of the injection solution, (B) mucosal lifting height and (C) injection pressure versus time trend graph. DETAILED DESCRIPTION

[0033] Example 1

[0034] A hemostatic and antibacterial injectable microsphere for submucosal dissection, the preparation method of which is as follows:

[0035] (1) Under the condition of magnetic stirring in a 40°C water bath, 5 g of sodium alginate (SA) was uniformly dissolved in 200 mL of deionized water, and then a certain amount of sodium periodate (the molar ratio of sodium periodate to sodium alginate was 3:1) was weighed and added to the above solution. After stirring evenly, the mixture was reacted in the dark for 8 h, and then 5 mL of ethylene glycol was added and continued to stir for 1 h to terminate the reaction; the above reaction solution was transferred to a dialysis bag with a molecular weight cutoff of 3500 Da, and dialyzed in deionized water for 3 days, with the water changed 2 to 3 times a day; the dialyzed solution was divided into culture dishes and transferred to a freeze dryer for freeze drying at -50°C for 12 h to obtain an oxidized sodium alginate (OSA) sample.

[0036] (2) In a 40℃ water bath with magnetic stirring, 1g OSA was uniformly dissolved in 100 mL of deionized water, and then a quantitative amount of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC) was added to the solution, wherein the molar ratio of OSA to EDC was 1:1, and the solution was stirred for 30 min to activate the carboxyl groups on the SA molecular chain; then L-cysteine ​​hydrochloride monohydrate (L-cysteine) of equal molar mass to OSA was added, and 0.1 mol / L sodium hydroxide solution was added dropwise while magnetic stirring until the cysteine ​​was completely dissolved, and the solution pH was adjusted to about 5, and the reaction was carried out in a light-proof environment at 25°C for 3 h; the reaction solution was transferred to a dialysis bag with a molecular weight cutoff of 8 to 14 kDa, and dialyzed in a 0.1 mM hydrochloric acid solution for 3 days, with the hydrochloric acid solution being replaced 2 to 3 times a day; the dialyzed solution was divided into culture dishes and loaded into a freeze dryer and freeze-dried for 12 h at -50°C to obtain a cysteine-grafted oxidized sodium alginate (cys-OSA) sample.

[0037] (3) Under the condition of magnetic stirring in a water bath at 40°C, 1 g of OSA was uniformly dissolved in 100 mL of deionized water, and then serotonin hydrochloride of equal molar mass to OSA was added to the solution and stirred evenly; 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC) and N-hydroxysuccinimide (NHS) were added to the solution, wherein the molar ratio of EDC to NHS was 2:1, and the pH of the reaction solution was adjusted to 5.5 with 0.1 mol / L sodium hydroxide, and the reaction was protected from light for 12 h; the above reaction solution was transferred to a dialysis bag with a molecular weight cutoff of 3500 Da, dialyzed in deionized water for 3 days, and the water was changed 2 to 3 times a day; the dialyzed solution was divided into culture dishes and transferred to a freeze dryer and freeze-dried at -50°C for 12 h to obtain a serotonin-grafted oxidized sodium alginate (s-OSA) sample.

[0038] (4) SA, cys-OSA and s-OSA (mass ratio of 1:1:1) were mixed and dissolved in deionized water to prepare a uniform solution with a mass concentration of 2 g / L. 500 μL of Span-80 and 100 μL of Tween-80 were added to 50 mL of liquid paraffin to prepare an oil phase, and then the above uniform solution was slowly dripped into the oil phase and mechanically stirred for 1 h (speed 500 rpm) in a 30°C water bath environment to form an oil-in-water system. A FeCl3 solution with a concentration of 2 mol / L was prepared and then slowly dripped into the above oil-in-water system at a uniform speed, and the mechanical stirring reaction was continued for 2 h. The reaction solution was poured into a 50 mL centrifuge tube and centrifuged at 4000 rpm for 10 min. The product was then washed with isopropanol, ethanol, and deionized water in turn, and filtered several times to remove impurities. Finally, the product was transferred to a freeze dryer and freeze-dried for 12 h to obtain SA / cOSAS. Fe Microspheres.

[0039] Example 2

[0040] The contents of the hemostatic and antibacterial injectable microspheres for submucosal dissection are substantially the same as those of Example 1, except that the molar ratio of sodium periodate to sodium alginate in step (1) is 2:1.

[0041] Example 3

[0042] The contents of the hemostatic and antibacterial injectable microspheres for submucosal dissection are substantially the same as those of Example 1, except that the molar ratio of sodium periodate to sodium alginate in step (1) is 1:1.

[0043] Example 4

[0044] The contents of a hemostatic and antibacterial injectable microsphere for submucosal dissection are substantially the same as those of Example 1, except that the molar ratio of L-cysteine ​​hydrochloride monohydrate to oxidized sodium alginate in step (2) is 2:1; and the molar ratio of serotonin hydrochloride to oxidized sodium alginate in step (3) is 2:1.

[0045] Example 5

[0046] The content of the hemostatic and antibacterial injectable microspheres for submucosal dissection is basically the same as that of Example 1, except that in step (4), the mass ratio of cysteine-grafted oxidized sodium alginate, serotonin-grafted oxidized sodium alginate and sodium alginate is 3:3:1.

[0047] Comparative Example 1

[0048] The content of an injectable microsphere is substantially the same as that of Example 1, except that the mass ratio of cysteine-grafted oxidized sodium alginate to sodium alginate in step (4) is 2:1, and serotonin-grafted oxidized sodium alginate is not added to prepare SA / cOSA Fe Microspheres.

[0049] Comparative Example 2

[0050] The content of an injectable microsphere is substantially the same as that of Example 1, except that the mass ratio of oxidized sodium alginate grafted with serotonin to sodium alginate in step (4) is 2:1, and oxidized sodium alginate grafted with cysteine ​​is not added to prepare SA / OSAS Fe Microspheres.

[0051] Test Case

[0052] The microspheres obtained in Example 1 and Comparative Examples 1-2 were subjected to relevant performance tests, and the test contents and methods are as follows:

[0053] 1. Morphology and Particle Size Analysis of Injectable Microspheres

[0054] The three types of microspheres were dispersed in deionized water to prepare a 0.1% w / w solution. The microspheres were photographed under an optical microscope and the morphology and particle size of the microspheres were statistically analyzed using ImageJ software. The freeze-dried microspheres were glued to the conductive glue and treated with gold by sputtering for 45 seconds. The microsphere morphology was then observed by scanning electron microscopy at an accelerating voltage of 3 kV. Figure 1 .A It can be seen that the microspheres of each group formed by the emulsion method and Fe ion cross-linking are well formed, and the particles between the microspheres are completely dispersed, and the diameter of the microspheres is less than 1μm. The SEM images taken were analyzed by ImageJ software (see Figure 1 .BC) It can be concluded that the particle size distribution of microspheres is concentrated between 0.1 and 0.5 μm, SA / cOSA Fe , SA / OSAS Fe , SA / cOSAS Fe The average particle sizes of the three microspheres are 0.58, 0.32 and 0.36 μm, respectively. The particle sizes of the prepared microspheres are all less than 2.5 μm, which will not affect the subsequent injection process.

[0055] 2. Characterization of the photothermal antibacterial properties of injectable microspheres

[0056] (1) A certain amount of microspheres were spread flat in a glass culture dish to form a coating of 1 x 1 cm and 3 mm thick, and a certain amount of PBS solution was dripped on the surface of the microspheres until the microspheres were completely wetted; a near-infrared light source with a wavelength of 808 nm was used to irradiate the microspheres for 3 min at a distance of about 15 cm above the microspheres, and a thermal imaging camera was used to capture photothermal images and record temperature changes. The images and temperature changes were continuously recorded after the near-infrared light source was removed. Figure 2 There are three types of microspheres SA / cOSA Fe 、SA / OSAS Fe 、SA / cOSAS Fe Real-time thermal imaging changes of microspheres within 3 minutes; it can be seen that all three microspheres have a certain photothermal responsiveness, and bright spots appear in the irradiated area, SA / OSAS Fe The bright spot area of ​​the microspheres at 3 minutes is the largest, and the temperature is the highest, reaching 55°C. This is because Fe ions and serotonin molecules can produce a synergistic effect, thereby enhancing the photothermal responsiveness. The temperature rise curve of the microspheres is obtained by statistically analyzing the thermal imaging change trend at each moment ( Figure 2 .B), it can be seen from the figure that the heating rates of the three microspheres in the first 20s are roughly the same, SA / cOSA Fe The heating rate of the microspheres began to decrease after 20 seconds and gradually stabilized at 44.4°C, while SA / OSAS FeThe temperature of the microspheres gradually increased from 53.4℃ to 55.5℃ after 60s; while SA / cOSAS Fe The microspheres were relatively moderate, reaching a temperature of 47.7°C after 3 min of irradiation. Figure 2 .C is the cooling curve of the microspheres after the near-infrared irradiation is removed. It can be seen that the microspheres can be cooled to the initial temperature in about 30 seconds, which can effectively avoid thermal damage to the tissue caused by continuous high temperature.

[0057] (2) Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus) were selected as the target test strains. 10 mg of microspheres from each group were weighed and added to a 24-well plate, and then placed in a clean bench and sterilized with ultraviolet light for 30 minutes; 100 μL of bacterial solution was added to each well, and 1 mL of PBS solution was added to the reference group. Then, 808 nm near-infrared light was irradiated at 15 cm above the well plate for 10 minutes, and the well plate was transferred to a 37°C incubator for incubation for 24 hours; 900 μL of PBS solution was added to each well and mixed evenly, and finally 100 μL of bacterial solution was drawn from each well and evenly smeared on the agar base, and incubated in a 37°C incubator for 24 hours. Finally, the colonies on the agar were counted, and the antibacterial rate was calculated by the following formula:

[0058]

[0059] A and A0 are the colony numbers in the experimental group and the control group, respectively.

[0060] When bacteria are exposed to temperatures above 45°C for a long time, the enzymes inside them will denature, causing them to lose their normal conformation and activity, leading to their death. Figure 3 .A and B are the colony images and inhibition rates of S. aureus and E. coli after near-infrared light irradiation of microspheres. Fe 、SA / cOSAS Fe It has a good killing effect on the two bacteria, with an inhibition rate of 95%; combined with photothermal responsiveness analysis, the two microspheres can reach a temperature above 45°C when irradiated for 3 minutes, causing the bacteria to be unable to survive normally, while SA / cOSA Fe The microspheres can only inactivate some bacteria and cannot match the antibacterial effect of the other two groups of microspheres.

[0061] 3. Characterization of the Antioxidant Properties of Injectable Microspheres

[0062] (1) The antioxidant properties of the microspheres were evaluated by scavenging two free radicals, 1,1-diphenyl-2-picrylhydrazyl (DPPH) and 2,2'-azobis(3-ethylbenzothiazoline-6-sulfonic acid ammonium salt) (ABTS); 20 mg of microspheres from each group were soaked in 5 mL of PBS and incubated in an oscillator at 37°C for 30 min, then the solution was centrifuged (120 rpm); 1 mL of the supernatant was mixed with 3 mL of DPPH ethanol solution and reacted in a 37°C water bath in the dark for 30 min; the absorbance at 512 nm was measured using an ultraviolet spectrophotometer, and the blank group was set to react with 1 mL of PBS and DPPH solution. The free radical scavenging efficiency (K) was calculated as follows:

[0063]

[0064] Where A1 is the absorbance of the blank group, and A0 is the absorbance of the sample group.

[0065] (2) Similarly, by replacing the DPPH solution in the above test with ABTS solution, the free radical scavenging rate of each group of microspheres for ABTS can be obtained.

[0066] (3) Figure 4 .A and B show SA / OSAS with serotonin Fe 、SA / cOSAS Fe The scavenging efficiency of the microspheres for DPPH and ABTS free radicals can reach more than 80%, which is due to the reaction of the indole structure in the serotonin molecule and the hydroxyl groups on the indole ring with the free radicals to achieve the scavenging effect; from the photos taken, it can be seen that as the free radical scavenging rate increases, the solution after the reaction with DPPH changes from dark purple to light yellow, and the solution after the reaction with ABTS changes from blue to almost colorless. In contrast, SA / cOSA containing only cysteine Fe The free radical scavenging rates of the microspheres for DPPH and ABTS were low, 63.6±3.0% and 65.9±2.0%, respectively. In conclusion, the introduction of serotonin can make the Fe ion cross-linked microspheres have better antioxidant capacity and maintain a high free radical scavenging effect.

[0067] 4. Characterization of hemostatic and blood-compatibility properties of injectable microspheres

[0068] (1) Weigh 50 mg of microspheres and spread them on the surface of a plastic culture dish in a circle with a diameter of 1 cm. No microspheres were added to the blank group, and medical gauze was set as the control group. Then, 100 μL of anticoagulated sheep blood and 15 μL of 0.25 M CaCl2 solution were added to the surface of each group of samples. After reacting at room temperature for 5 minutes, the uncoagulated blood in the culture dish was rinsed with deionized water. The dissolved solution was transferred to a 96-well plate, and the absorbance of the solution at 540 nm was read using an ELISA reader. The blood coagulation index (BCI) was calculated as follows:

[0069]

[0070] Among them, I S ,I0,I E They are the absorbance of sample, deionized water and blank control group at 540nm respectively.

[0071] from Figure 5 .A It can be seen that after adding deionized water to the blank group, the blood and water are directly soluble and the blood cannot coagulate; after rinsing with deionized water, the medical gauze group saw the liquid change color, proving that some blood has not coagulated; for the microsphere group, after adding deionized water, it can be clearly seen that the blood coagulates into lumps, and the color of the solution changes little. The supernatant after rinsing is collected in the well plate and measured by the microplate reader. Figure 5 .B (Coagulation index graph); It can be seen that the coagulation index of the microsphere group at 5 minutes was significantly lower than that of the medical gauze, indicating better hemostatic performance; the coagulation index containing serotonin was even lower, because both serotonin and Fe ions can act as coagulation mediators to promote the coagulation process.

[0072] (2) Place an equal amount of each group of microspheres in a PBS solution and soak for 24 hours, then centrifuge the solution to obtain the supernatant to obtain the microsphere extract; measure 2mL of anticoagulated sheep whole blood into a centrifuge tube, centrifuge at 1500rpm for 10 minutes, remove the supernatant, and then repeat the above centrifugation washing with PBS solution 3 times; mix the bottom red blood cells with 8mL of PBS solution and resuspend, then mix the microsphere extract and the red blood cell suspension at a volume ratio of 1:1, and incubate in a shaker at 37℃ for 1 hour and then centrifuge for 5 minutes; transfer the supernatant after centrifugation to a 96-well plate, and read the absorbance at 540nm using an enzyme reader; set PBS solution as the negative control group and deionized water as the positive control group for testing. The hemolysis rate (HR) calculation formula is as follows:

[0073]

[0074] Among them, A s , A n , A p Represent the absorbance of the sample group, negative group and positive group at 540nm respectively.

[0075] like Figure 5 As shown in Figures C and D, the colors of the three microsphere groups after centrifugation with red blood cells were significantly different from those of the deionized water group, but similar to those of the PBS group. Bright red represents a higher hemolysis rate, while colorless represents a lower hemolysis rate. The absorbance of the supernatant was measured by an ELISA instrument to calculate the hemolysis rate of each group ( Figure 6 .D), the results showed that the hemolysis rates of the microsphere groups were all much less than 5%, which met the international safety standards for the hemolysis rate of materials, indicating that the three groups of microspheres had good blood compatibility.

[0076] 5. Characterization of the interventional therapeutic performance of injectable microspheres

[0077] (1) Purchase fresh pig stomach, wash it with saline, cut it into strips of 5 cm in length and 2 cm in width, lay it flat on the table with the inner wall of the mucosa facing up, and measure its original thickness; weigh an equal amount of each group of microsphere samples and disperse them in PBS solution (pH = 7.4) for later use, use a 25G syringe to draw 5 mL of each group of microsphere dispersion and inject it into the submucosal layer, set up saline as a control group for comparison, measure the height of the mucosal bulge immediately after the injection, and measure the height of the mucosal bulge in turn after 0.5, 1, 5, 10 and 20 minutes to obtain the relationship between the change of the mucosal bulge height and time; and use a material texture analyzer to record the relationship between the pressure and time during the injection of each group of microspheres. All animal experiments in this study were approved by the Ethics Committee of Zhengzhou University, in compliance with ISO 10993-2:2006 standards, and the experimental operations were strictly carried out in accordance with the guidelines.

[0078] (2) Evaluation of SA / cOSA using a porcine stomach in vitro model Fe 、SA / OSAS Fe 、SA / cOSAS Fe The submucosal bulge performance of the three microspheres was measured by photographing and recording the bulge height of the mucosa after injection. Figure 6 A; From the figure, it can be seen that the height of the mucosal bulge began to gradually decrease 30s after the injection of normal saline, and the bulge could not be clearly seen at 5 minutes, while the microsphere group could still see obvious mucosal bulge after 5 minutes; the recorded data were plotted to obtain the relationship between the height of the bulge after injection and the time ( Figure 6 .B), it can be seen that the height of the mucosal bulge of normal saline dropped rapidly from 8.8±0.8mm to 5.7±0.4mm 1min after injection; the change trend of the lifting height of each microsphere group within 1min was basically the same, all decreased by about 1mm, and the diffusion rate of the injection solution was much lower than that of normal saline, and the mucosal bulge of more than 7mm could still be maintained at 20min, providing an effective guarantee for the smooth progress of ESD surgery.

[0079] The injection pressure of each group was obtained with the physical property analyzer over time. Figure 6 .C), static friction needs to be overcome when the microsphere solution is extruded, so the injection pressure increases significantly; in the subsequent extrusion process, the injection pressure of the injection solution tends to be stable, and the injection pressure of saline is between 0.5 and 1N, SA / cOSA Fe The injection pressure of the microsphere injection was the highest, approximately between 1 and 1.5 N. It is worth noting that the injection pressures of the three groups of microsphere injections were not significantly different from those of normal saline, which enabled them to reach the injection site smoothly during operation without the risk of blockage.

Claims

1. A hemostatic and antibacterial injectable microsphere for submucosal dissection, characterized in that: The hemostatic and antibacterial injectable microspheres are based on oxidized sodium alginate modified by grafting of cysteine ​​and serotonin, and a composite of sodium alginate and trivalent iron ions; the average particle size of the hemostatic and antibacterial injectable microspheres is 0.1-0.5 μm.

2. A method for preparing hemostatic and antibacterial injectable microspheres, characterized in that: The following steps are involved: (1) Dissolve sodium periodate in sodium alginate solution, stir and mix, and then react in the dark for 8 h, then add ethylene glycol and continue stirring for 1 h to terminate the oxidation reaction to obtain a reaction solution, dialyze the reaction solution, and freeze-dry to obtain oxidized sodium alginate; (2) first adding 1-ethyl-(3-dimethylaminopropyl) carbodiimide hydrochloride to the oxidized sodium alginate solution, stirring for reaction, then adding L-cysteine ​​hydrochloride monohydrate, adjusting the pH of the solution to about 5 with sodium hydroxide solution, and then reacting in the dark to obtain a reaction solution, dialyzing the reaction solution, and freeze-drying it to obtain cysteine-grafted oxidized sodium alginate; (3) adding serotonin hydrochloride to the oxidized sodium alginate solution and stirring evenly, then adding 1-ethyl-(3-dimethylaminopropyl) carbodiimide hydrochloride and N-hydroxysuccinimide, adjusting the pH of the solution to 5.5 with a sodium hydroxide solution, and then reacting in the dark to obtain a reaction solution, dialyzing the reaction solution, and freeze-drying it to obtain serotonin grafted oxidized sodium alginate; (4) The cysteine-grafted oxidized sodium alginate, serotonin-grafted oxidized sodium alginate and sodium alginate obtained above are mixed and dissolved in deionized water to prepare a uniform solution, which is then dropped into the oil phase and stirred to obtain an oil-in-water system; then the FeCl3 solution is dropped into the above oil-in-water system, stirred for reaction, and a reaction emulsion is obtained; the reaction emulsion is centrifuged, the product is collected and washed, filtered, and freeze-dried to obtain the hemostatic and antibacterial injectable microspheres.

3. The preparation method according to claim 2, characterized in that: In the step (1), the molar ratio of sodium periodate to sodium alginate is (1-3):

1.

4. The preparation method according to claim 2, characterized in that: In the step (2), the molar ratio of L-cysteine ​​hydrochloride monohydrate to oxidized sodium alginate is (1-2):1; the molar ratio of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride to oxidized sodium alginate is 1:

1.

5. The preparation method according to claim 2, characterized in that: In the step (3), the molar ratio of serotonin hydrochloride to sodium alginate oxide is (1-2):1; the molar ratio of 1-ethyl-(3-dimethylaminopropyl) carbodiimide hydrochloride to N-hydroxysuccinimide is 2:

1.

6. The preparation method according to claim 2, characterized in that: In the step (4), the mass ratio of cysteine-grafted oxidized sodium alginate, serotonin-grafted oxidized sodium alginate and sodium alginate is (1-3):(1-3):

1.

7. The preparation method according to any one of claims 2 to 6, characterized in that: The concentration of the sodium hydroxide solution is 0.1 mol / L.

8. The preparation method according to claim 7, characterized in that: The mass concentration of the uniform solution in step (4) is 2 g / L, the oil phase is liquid paraffin containing Span-80 and Tween-80, and the concentration of the FeCl3 solution is 2 mol / L.

9. Hemostatic and antibacterial injectable microspheres for submucosal dissection prepared by the method according to any one of claims 2 to 8.